Developing Objective Fatigue Indicators in Colorectal Cancer Survivors.
|ClinicalTrials.gov Identifier: NCT01700283|
Recruitment Status : Unknown
Verified October 2012 by National Taiwan University Hospital.
Recruitment status was: Recruiting
First Posted : October 4, 2012
Last Update Posted : November 14, 2012
The aims of this four-year study are to
- Explore exercise behavior, exercise barriers, and identify the significant factors for exercise behavior in colorectal cancer survivors.
- Explore the relationships among fatigue, muscle strength, and metabolomics and further examine the possible biomarkers from muscle strength and metabolomics for fatigue.
- Develop a clinical guidelines of home-based fatigue management and exercise program and test its effect on decreasing fatigue for patients with colorectal cancer after surgery in Taiwan.
|Condition or disease||Intervention/treatment||Phase|
|Colorectal Cancer||Behavioral: exercise education and walking program||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||306 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Developing Objective Fatigue Indicators: Exploring the Relationships Among Fatigue, Muscle Power and Metabolomics Through Fatigue Management and Individualized Exercise Education Program in Colorectal Cancer Survivors.|
|Study Start Date :||October 2012|
|Estimated Primary Completion Date :||July 2015|
|Estimated Study Completion Date :||July 2015|
|Experimental: exercise education and walking program||
Behavioral: exercise education and walking program
12-week moderate intensity walking program
|No Intervention: maintain their daily activity|
- Developing Objective Fatigue Indicators: Exploring the Relationships Among Fatigue, Muscle Power and Metabolomics Through Fatigue Management and Individualized Exercise Education Program in Colorectal Cancer Survivors [ Time Frame: four-year study ]Develope the clinical exercise education program guideline for patients with early stage colorectal cancer survivor.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01700283
|Contact: Shiow-Ching Shun, PHD||886-2-23123456 ext firstname.lastname@example.org|
|National Taiwan University Hospital||Recruiting|
|Contact: Shiow-Ching Shun, PHD 886-2-2312-3456 ext 88439 email@example.com|
|Principal Investigator: Shiow-Ching Shun, PHD|
|Principal Investigator:||Shiow-Ching Shun, PhD||National Taiwan University|